Advisory Board

Gregory Gores

Scientific Advisory Board

Prof. Gregory J. Gores, MD, is a senior academician with broad contributions to research, clinical practice, education and leadership. His research contributions include sustained federal funding for more than 25 years, over 500 publications, an H-index of 103 and over 30,000 citations. Based on these accomplishments, he was appointed as a Distinguished Mayo Investigator. His clinical focus on cholangiocarcinoma and hepatobiliary neoplasia has led to pioneering work employing novel protocols for cholangiocarcinoma combined with liver transplantation. His leadership positions include past presidency of the American Association for the Study of Liver Disease and the International Liver Cancer Association. He is a current member of the American Gastroenterological Association Governing Board. He has also served as chair of the Gastroenterology and Hepatology Division at Mayo Clinic Rochester, medical director of the Liver Transplant Program, and is the current executive dean for research across the Mayo enterprise.

Jo Klaveness

Scientific Advisory Board / Research Partner

MSc Pharm. University of Oslo
Jo Klaveness is a professor of medical chemistry at the University of Oslo’s School of Pharmacy and the founder of Drug Discovery Laboratory AS. He has a doctoral degree and a master’s degree in organic chemistry as well as an MSc Pharm. in pharmaceutical chemistry from the University of Oslo. He has held several positions in Nycomed, including as project manager and head of the R&D organisation, and served in several boards of directors, including for Pronova Biopharma ASA and Omegatri AS. Klaveness is the inventor of more than 160 patent families related to several pharmaceutical products that are on the market.

Audun N. Øksendal

Scientific Advisory Board

Dr. Philos.
Øksendal is a former special adviser in biotechnology with the Research Council of Norway, and was CEO of Medinnova, now Inven2, which was responsible for medical innovation based at Oslo University Hospital. He is a Dr. Philos. with a doctorate in basic cardiology, and he worked for Nycomed Imaging for 15 years in different management functions in the areas of research, strategic planning and international marketing. He was responsible for the merger of the marketing departments of the Norwegian company Nycomed Imaging and the English company Amersham and was director of marketing for Europe and Asia. He is currently engaged in consultancy in the field of life sciences.